Named on one round in the feed.
Since 2026-09-24
ROUNDS
1
joined, none as lead
ROUNDS · USD
$34.2M
across 1 round
CO-INVESTORS
6
named beside it
Named on one round in the feed.
Since 2026-09-24
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Kasvu Therapeutics A company developing a new generation of neuroplastogens for neuropsychiatric and neurodegenerative disorders | Series A Verified against 1 source | $34.2M | 2026-09-24 | [ PART ] |
